Cumberland Pharmaceuticals (CPIX) EBT Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | -77.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.23% |
| Mar 31, 2026 | -169.18% |
| Dec 31, 2025 | 16.73% |
| Sep 30, 2025 | -67.12% |
| Jun 30, 2025 | 18.70% |
| Mar 31, 2025 | 42.58% |
| Dec 31, 2024 | 23.50% |
| Sep 30, 2024 | 1.08% |
| Jun 30, 2024 | -51.69% |
| Mar 31, 2024 | -76.61% |
| Dec 31, 2023 | -52.29% |
| Sep 30, 2023 | 6.00% |
| Jun 30, 2023 | 36.08% |
| Mar 31, 2023 | 28.00% |
| Dec 31, 2022 | 10.61% |
| Sep 30, 2022 | 49.91% |
| Jun 30, 2022 | -0.59% |
| Mar 31, 2022 | -3.22% |
| Dec 31, 2021 | 10.07% |
| Sep 30, 2021 | 1.71% |